INTENDED USE

The Advanced Quality Typhoid IgM/IgG Rapid Test is a colloidal gold enhanced, rapid immunochromatographic assay for the qualitative detection of IgG & IgM antibodies to Typhoid in human whole blood, serum or plasma, and serves as an aid in the diagnosis of Typhoid infections. It only provides preliminary analysis results but not critical diagnosis criteria, the obtained results should be analyzed in connection with other clinical information, e.g. clinical symptoms, and using more specific alternative diagnosis methods to make final decision. This test is a screening test, and all positives must be confirmed using an alternate test. The test is intended for healthcare professional use only.

Sensitive Detection and Differentiationof s. Typhiand Paratyphi

INTENDED USE

The Advanced Quality S. Typhi/Paratyphi Ag Combo Rapid Test is an immunochromatograpic assay for qualitative detection of antigens to Typhoid and paratyphoid inhuman whole blood, serum, plasma or fecal specimen. The test is a non-automated rapid test used as an aid for diagnosis, and all positive results must be confirmed usingan appropriate test such as bacterial culture. It is intended for in vitro diagnosis of clinical conditions related to the patients suspected/infected with Typhoid and paratyphoid by healthcare professionals and appropriately trained personal.

INTENDED USE

The Monkeypox Virus Antigen Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection of monkeypox virus antigen in human whole blood, serum, plasma, rash exudate or throat swab specimen. It only provides preliminary analysis results but not critical diagnosis criteria, the obtained results should be analyzed in connection with other clinical information, e.g. clinical symptoms, and using more specific alternative diagnosis methods to make final decision. This test is a screening test, and all positives must be confirmed using an alternate test. The test is intended for healthcare professional use only.

Comprehensive Testing Made Effortless

The test is a rapid immunochromatographic assay for qualitative detection of ABO/RhD blood group antigens and antibodies for HIV, Syphilis, Hepatitis B (HBsAg), and Hepatitis C in fingerstick or venous whole blood, Designed for professional use. It provides non-automated results quickly and accurately.

One Step Multi-Infectious Disease Test is an in vitro, rapid qualitative immunoassay for the detection of human immunodeficiency virus (HIV)

1/2 antibodies, hepatitis C virus (HCV) antibodies, Treponema pallidum (TP) antibodies, and hepatitis B virus (HBV) surface antigen in human

whole blood, serum or plasma.

This test is intended for healthcare professionals and trained healthcare workers as an aid for diagnosis of HIV, HCV, TP or HBV infection.

Enabling TORCH screening at the point of care

Exclusive method

Solid-phase method

Accuracy rate: 100%

INTENDED USE

The kit is intended to qualitatively detect ABO blood group system A/B antigen and Rh blood group system D antigen in fresh finger prick blood/ anticoagulated venous whole blood.

Human blood contains a wide variety of blood groups, of which ABO and RhD are the most common. Blood group identification is a crucial test item prior to clinical blood transfusion, and has important clinical significance. When the blood group antigen on the surface of red blood cells comes in contact with the corresponding antibody, red blood cells will undergo agglutination reaction, which will eventually lead to hemolysis of red blood cells and endanger life. As a result, correct identification of ABO and RhD blood antigens is an essential prerequisite to ensure safe blood transfusion and avoid related diseases.

Ultra Sensitive

INTENDED USE

The AQ+ COVID-19 Ag Rapid Test is a colloidal gold enhanced, rapid immunochromatographic assay for qualitative detection of SARS-CoV-2 antigens in the nasopharyngeal/ nasal specimen collected by swabs from individuals who are suspected of having COVID-19. The test is used as an aid in the diagnosis of SARS-CoV-2 infection. The test is suitable for use under healthcare professional supervision. Individuals should have appropriate training in how to administer the test correctly. Remote healthcare professional supervision can be used with appropriate clinical governance, once training has been completed and verified.